Boston Scientific sells microsphere business, readies for $4.2B UK acquisition

Spinal Tech

Varian Medical is purchasing Boston Scientific's microsphere business for $90 million as the Marlborough, Mass.-based medical device company prepares for a $4.2 billion acquisition of BTG, a cancer and vascular disease company, reports Worcester Business Journal.

Three things to know:

1. Varian Medical will acquire Oncozene, Embozene and Embozene Tandem, Boston Scientific's products that treat arteriovenous malformations in the brain and spine.

2. The three products accumulated $21.2 million in sales in 2018.

3. The deal will be completed after Boston Scientific finalizes the acquisition of BTG, expected in August.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like

 

Featured Webinars

Featured Whitepapers